Logo
x

Search

Subscribe Now

bergenbio

BerGenBio Reports the Data from P-Ib/IIa (BGBC016) Clinical Evaluation of Bemcentinib as 1L Treatment of NSCLC

BerGenBio Reports the Data from P-Ib/IIa (BGBC016) Clinical Evaluation of Bemcentinib as 1L Treatment of NSCLC

  • October 7, 2024
BerGenBio and Tempus Collaborate to Advance the Development of STK11m to Treat NSCLC

BerGenBio and Tempus Collaborate to Advance the Development of STK11m to Treat NSCLC

  • August 22, 2024
PharmaShots Weekly Snapshots (March 06 - 10, 2023)

PharmaShots Weekly Snapshots (March 06 - 10, 2023)

  • March 10, 2023
BerGenBio Reports P-II Trial Results of BGB324 (bemcentinib) as 2L Treatment of Non-Small Cell Lung Cancer

BerGenBio Reports P-II Trial Results of BGB324 (bemcentinib) as 2L Treatment of Non-Small Cell Lung Cancer

  • February 16, 2023
Bergenbio Reports Results of Bemcentinib in P-II (ACCORD2) Study for the Treatment of COVID-19

Bergenbio Reports Results of Bemcentinib in P-II (ACCORD2) Study for the Treatment of COVID-19

  • April 26, 2022
PharmaShots Weekly Snapshot (October 21-25, 2019)

PharmaShots Weekly Snapshot (October 21-25, 2019)

  • October 29, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.